| BRAND NAME | APPLICATION | SPONSOR | STATUS |
|---|---|---|---|
| LUCENTIS | BLA125156 | GENENTECH | Prescription |
| SUSVIMO | BLA761197 | GENENTECH INC | Prescription |
| PRODUCT NAME | HOLDER | STATUS | DATE | INDICATION |
|---|---|---|---|---|
| Byooviz | Samsung Bioepis NL B.V. | Authorised | 18/08/2021 | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Myopia, Degenerative |
| Ranluspec | Lupin Europe GmbH | Authorised | 10/02/2026 | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complicatio… |
| Rimmyrah | Qilu Pharma Spain S.L. | Authorised | 05/01/2024 | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerati… |
| Lucentis | Novartis Europharm Limited | Authorised | 22/01/2007 | Wet Macular Degeneration;Macular Edema;Diabetes Complications;Myopia, Degenerati… |
| Ranivisio | Midas Pharma GmbH | Authorised | 25/08/2022 | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complicatio… |
| Epruvy (previously Ranibizumab Midas) | Midas Pharma GmbH | Authorised | 19/09/2024 | Wet Macular Degeneration;Macular Edema;Choroidal Neovascularization;Diabetes Com… |
| Ximluci | STADA Arzneimittel AG | Authorised | 09/11/2022 | Wet Macular Degeneration;Macular Edema;Diabetic Retinopathy;Diabetes Complicatio… |
| Susvimo | Roche Registration GmbH | Application withdrawn | Wet Macular Degeneration |